Web Results

Sunitinib - Wikipedia


Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell ...

RCC | GIST | PNET | SUTENT® (sunitinib malate) Safety Info ...


SUTENT® (sunitinib malate) for treatment of advanced renal cell carcinoma, gastrointestinal stromal tumors & advanced pancreatic NET. Risk info for SUTENT®.

Sunitinib: MedlinePlus Drug Information


Aug 15, 2016 ... Sunitinib: learn about side effects, dosage, special precautions, and more on MedlinePlus.

Sunitinib - Chemotherapy Drugs - Chemocare


Trade Name: Sutent <sup>®</sup> Other Name: SU11248. Drug Type: Sunitinib is a targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It inhibits the actions ...

Sunitinib (Sutent) | Cancer Research UK


May 12, 2015 ... Read about the cancer treatment drug sunitinib, otherwise known as Sutent, including what it is, how it works and possible side effects.

Sunitinib Malate - National Cancer Institute


Oct 5, 2006 ... This page contains brief information about sunitinib malate and a collection of links to more information about the use of this drug, research ...

Definition of sunitinib malate - NCI Drug Dictionary - National ...


Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and ...

Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era ...


Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor tyrosine kinases (RTKs). These include vascular endothelial growth factor ...

Sunitinib: Indications, Side Effects, Warnings - Drugs.com


Jan 6, 2017 ... Easy to read patient leaflet for sunitinib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Sutent (Sunitinib Malate): Side Effects, Interactions, Warning ... - RxList


SUTENT, an oral multi-kinase inhibitor, is the malate salt of sunitinib. Sunitinib malate is described chemically as Butanedioic acid, hydroxy-, (2S)-, compound ...